3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS

The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or sc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: COATES, David Andrew, REINHARD, Matthew Robert, BEADLE, Christopher David, SCHAUS, John Mehnert, WOLFANGEL, Craig Daniel, HAO, Junliang, KRUSHINSKI JR., Joseph Herman
Format: Patent
Sprache:eng ; lit
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator COATES, David Andrew
REINHARD, Matthew Robert
BEADLE, Christopher David
SCHAUS, John Mehnert
WOLFANGEL, Craig Daniel
HAO, Junliang
KRUSHINSKI JR., Joseph Herman
description The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LT3004061TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LT3004061TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LT3004061TT3</originalsourceid><addsrcrecordid>eNrjZNA01jHRdfH0iHQJ8vcM9g8M9fTz9_H00zXSMPTQ1I30UXD29w3wD_VzCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfE-IcYGBiYGZoYhIcZEKAEAzP4kFg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><source>esp@cenet</source><creator>COATES, David Andrew ; REINHARD, Matthew Robert ; BEADLE, Christopher David ; SCHAUS, John Mehnert ; WOLFANGEL, Craig Daniel ; HAO, Junliang ; KRUSHINSKI JR., Joseph Herman</creator><creatorcontrib>COATES, David Andrew ; REINHARD, Matthew Robert ; BEADLE, Christopher David ; SCHAUS, John Mehnert ; WOLFANGEL, Craig Daniel ; HAO, Junliang ; KRUSHINSKI JR., Joseph Herman</creatorcontrib><description>The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.</description><language>eng ; lit</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171127&amp;DB=EPODOC&amp;CC=LT&amp;NR=3004061T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171127&amp;DB=EPODOC&amp;CC=LT&amp;NR=3004061T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COATES, David Andrew</creatorcontrib><creatorcontrib>REINHARD, Matthew Robert</creatorcontrib><creatorcontrib>BEADLE, Christopher David</creatorcontrib><creatorcontrib>SCHAUS, John Mehnert</creatorcontrib><creatorcontrib>WOLFANGEL, Craig Daniel</creatorcontrib><creatorcontrib>HAO, Junliang</creatorcontrib><creatorcontrib>KRUSHINSKI JR., Joseph Herman</creatorcontrib><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><description>The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNA01jHRdfH0iHQJ8vcM9g8M9fTz9_H00zXSMPTQ1I30UXD29w3wD_VzCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfE-IcYGBiYGZoYhIcZEKAEAzP4kFg</recordid><startdate>20171127</startdate><enddate>20171127</enddate><creator>COATES, David Andrew</creator><creator>REINHARD, Matthew Robert</creator><creator>BEADLE, Christopher David</creator><creator>SCHAUS, John Mehnert</creator><creator>WOLFANGEL, Craig Daniel</creator><creator>HAO, Junliang</creator><creator>KRUSHINSKI JR., Joseph Herman</creator><scope>EVB</scope></search><sort><creationdate>20171127</creationdate><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><author>COATES, David Andrew ; REINHARD, Matthew Robert ; BEADLE, Christopher David ; SCHAUS, John Mehnert ; WOLFANGEL, Craig Daniel ; HAO, Junliang ; KRUSHINSKI JR., Joseph Herman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LT3004061TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; lit</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>COATES, David Andrew</creatorcontrib><creatorcontrib>REINHARD, Matthew Robert</creatorcontrib><creatorcontrib>BEADLE, Christopher David</creatorcontrib><creatorcontrib>SCHAUS, John Mehnert</creatorcontrib><creatorcontrib>WOLFANGEL, Craig Daniel</creatorcontrib><creatorcontrib>HAO, Junliang</creatorcontrib><creatorcontrib>KRUSHINSKI JR., Joseph Herman</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COATES, David Andrew</au><au>REINHARD, Matthew Robert</au><au>BEADLE, Christopher David</au><au>SCHAUS, John Mehnert</au><au>WOLFANGEL, Craig Daniel</au><au>HAO, Junliang</au><au>KRUSHINSKI JR., Joseph Herman</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS</title><date>2017-11-27</date><risdate>2017</risdate><abstract>The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; lit
recordid cdi_epo_espacenet_LT3004061TT
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A33%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COATES,%20David%20Andrew&rft.date=2017-11-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELT3004061TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true